Is ARRFX or JNJ a better dividend investment in 2026?

ARRFX currently yields 13.63% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ARRFX offers higher current income.

What is the dividend yield difference between ARRFX and JNJ?

ARRFX has a forward dividend yield of 13.63% ($1.69/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 10.27 percentage points.

Home › Compare › ARRFX vs JNJ

ARRFX vs JNJ: Dividend Comparison 2026

ARRFX yields 13.63% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARRFX wins by $29.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ARRFX

● Live price

13.63%

Share price

$12.43

Annual div

$1.69

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.0K

Annual income

$3,173.85

Full ARRFX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ARRFX vs JNJ

📍 ARRFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ARRFX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ARRFX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ARRFX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARRFX

Annual income on $10K today (after 15% tax)

$1,158.20/yr

After 10yr DRIP, annual income (after tax)

$2,697.77/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ARRFX beats the other by $1,994.16/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARRFX + JNJ for your $10,000?

ARRFX: 50%JNJ: 50%

100% JNJ50/50100% ARRFX

Portfolio after 10yr

$34.5K

Annual income

$2,000.82/yr

Blended yield

5.80%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ARRFX

No analyst data

Altman Z

0.8

Piotroski

7/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARRFX buys

JNJ buys

No recent congressional trades found for ARRFX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricARRFXJNJ

Forward yield	13.63% ✓	3.36%
Annual dividend / share	$1.69	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$49.0K ✓	$20.0K
Annual income after 10y	$3,173.85 ✓	$827.78
Total dividends collected	$22.3K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ARRFX vs JNJ ($10,000, DRIP)

Year	ARRFX Portfolio	ARRFX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,063	$1,362.59	$10,676	$355.77	+$1.4K → ARRFX
2	$14,443	$1,536.11	$11,407	$389.39	+$3.0K → ARRFX
3	$17,173	$1,718.93	$12,198	$426.53	+$5.0K → ARRFX
4	$20,285	$1,910.12	$13,056	$467.62	+$7.2K → ARRFX
5	$23,814	$2,108.68	$13,987	$513.12	+$9.8K → ARRFX
6	$27,794	$2,313.54	$14,998	$563.56	+$12.8K → ARRFX
7	$32,264	$2,523.60	$16,098	$619.52	+$16.2K → ARRFX
8	$37,260	$2,737.74	$17,295	$681.69	+$20.0K → ARRFX
9	$42,823	$2,954.85	$18,599	$750.82	+$24.2K → ARRFX
10	$48,994	$3,173.85	$20,022	$827.78	+$29.0K → ARRFX

ARRFX vs JNJ: Complete Analysis 2026

ARRFX — Stock

The fund principally invests in a portfolio of equity securities of U.S. and non-U.S. companies and may invest in securities of all market capitalizations. Under normal conditions, the advisor intends to invest the fund's assets in the equity securities of a limited number of issuers. It will primarily invest in common stocks, real estate investment trusts ("REITs") and publicly traded partnerships ("PTPs"), including, but not limited to, master limited partnerships ("MLPs"). The fund is non-diversified.

Full ARRFX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ARRFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARRFX vs SCHD ARRFX vs JEPI ARRFX vs O ARRFX vs KO ARRFX vs MAIN ARRFX vs ABBV ARRFX vs MRK ARRFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.